Genetically Determined Metabolites in Graves Disease: Insight From a Mendelian Randomization Study
Yao Tan, Jiayang Yin, Jiamin Cao, Bingyu Xie, Feng Zhang, Wei Xiong · 2023
Read Genetically Determined Metabolites in Graves Disease: Insight From a Mendelian Randomization Study by Yao Tan, Jiayang Yin, Jiamin Cao, Bingyu Xie, Feng Zhang, Wei Xiong (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10729855.txt.
Description
Blood small molecules may push the thyroid into overdrive in Graves disease, and genes can test that push. Yao Tan, Jiayang Yin, Jiamin Cao, Bingyu Xie, Feng Zhang, and Wei Xiong run that test in a 2023 study. They use FinnGen data with 2,836 cases.
Nineteen molecules tied to disease risk at first pass. Ten held up under hard checks. One molecule, kynurenine, raised risk nearly fourfold per unit. Two others cut risk roughly in half. None of the three shared gene roots with the disease itself. That split supports a true causal push, they argue.
Catalog record
| CREATOR | Yao Tan, Jiayang Yin, Jiamin Cao, Bingyu Xie, Feng Zhang, Wei Xiong |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |